You choose, we deliver
If you are interested in this story, you might be interested in others from The Journal Gazette. Go to and pick the subjects you care most about. We'll deliver your customized daily news report at 3 a.m. Fort Wayne time, right to your email.


  • New-homesales slowto a trickle
    WASHINGTON – U.S. sales of new homes were nearly flat in September, after the government sharply revised downward what was initially an August surge in buying.New-home sales edged up 0.
  • Stocks see best week in 2 years
    NEW YORK – The stock market closed out its best week in nearly two years on a positive note Friday, helped by strong quarterly earnings from Microsoft and other big U.S. companies.
  • Ford quarterly profit falls
    DEARBORN, Mich. – Ford’s new aluminum-sided F-150 will be a lot lighter and more efficient when it goes on sale this year. But for now, it’s a serious drag on profits.

Symmetry Medical reports quarterly loss

Symmetry Medical Inc. today reported a first-quarter loss of $294,000, or 1 cent per diluted share, a drop of more than $1 million compared to the $830,000, or 2 cents a share, earnings posted for the same three months of last year.

The Warsaw-based maker of orthopedic implants, surgical instruments and sterilization cases said that without certain non-cash charges, it would have shown a profit of $2.26 million for the three months ended March 30. Those charges included stock compensation expense, management transition costs, acquisition-related costs, SEC-related legal costs, and facility closure and severance expenses.

In December 2011, Symmetry announced plans to acquire Codman & Shurtleff Inc., the Massachusetts-based surgical instruments business of Johnson & Johnson, for $165 million cash. Symmetry combined Codman’s line of general surgical instruments with its own Specialty Surgical Instrumentation to form Symmetry Surgical, which is based in Nashville, Tenn.

Thomas Sullivan, president and CEO, called Symmetry Surgical’s first-quarter sales disappointing.

“Internationally, sales to our new distributors have been weak as they transition regulatory authorizations, establish awareness with their hospital customers, and ramp up country-specific marketing and sales activities,” he said in a statement. He added that officials “believe we have identified the issues and are implementing corrective actions that we expect will gradually reinvigorate growth in Symmetry Surgical by year end.”